A new variant of COVID-19 may be driving up cases in some parts of the world, WHO says
Washington: COVID-19 cases are rising again as a new variant begins to circulate in some parts of the world. The
World Health Organization
said Wednesday the rise in cases is primarily in the eastern Mediterranean, Southeast Asia and western Pacific regions.
Airport screening in the United States has detected the new variant in travelers arriving from those regions to destinations in California, Washington state, Virginia and New York.
The new variant is called NB.1.8.1. It arrives as the United States' official stance on COVID-19 vaccination is changing. On Tuesday, Health Secretary Robert F. Kennedy Jr. announced that COVID-19 shots are no longer recommended for healthy children and pregnant women - a move immediately questioned by several public health experts.
The new variant, increasing globally, had by mid-May reached nearly 11% of sequenced samples reported. The WHO has designated it a "variant under monitoring" and considers the
public health risk
low at the global level with current vaccines expected to remain effective.
The WHO said some western Pacific countries have reported increases in COVID cases and hospitalizations, but there's nothing so far to suggest that the disease associated with the new variant is more severe compared to other variants.
The variant called LP.8.1 is currently the dominant version in the U.S. and globally. ___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The is solely responsible for all content.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
an hour ago
- Indian Express
GMCH's 259-bed Trauma Centre likely to open doors to patients in August
Chandigarh will get another dedicated trauma centre, this time at the Government Medical College and Hospital (GMCH), Sector 32. The long-awaited 259-bed trauma centre is now almost ready, and hospital authorities plan to inaugurate it in August. Dr G P Thami, Medical Superintendent, GMCH, said that construction work is complete and equipment procurement is currently underway. 'We had to postpone our 11th convocation earlier due to tensions between India and Pakistan. The new date for the convocation has been set for August 2. We hope to inaugurate the trauma centre on the same day and have sent the proposal to the UT Administration,' he said. The project was initially proposed in 2019 with a timeline of 18 months. It was expected to be operational by February 2022. However, the COVID-19 pandemic caused delays. The UT Administration had repeatedly emphasised the need for its early completion. Now, with work almost complete, the trauma centre is expected to ease space constraints in the current emergency wing. Officials say that the existing area could be used for other departments once trauma services are shifted to the new building. With this development, Chandigarh will have two dedicated trauma centres — one at PGI and another at GMCH. Currently, GMCH has around 150 beds for both emergency and trauma cases. The addition of the new trauma centre is expected to significantly reduce the burden. GMCH's trauma wing is a critical project. The need for expansion has been urgent, as the existing emergency wing has no room for additional beds. Former director Dr B S Chavan had secured ?52 crore for this project, with the goal of upgrading the emergency capacity to 259 beds. Until now, trauma and emergency patients have been managed in a common space, often resulting in overcrowding, with some patients treated on trolleys. Once the new trauma facility becomes operational, the hospital will have improved capacity and infrastructure to manage high-volume critical cases more efficiently. If all goes as per plan, the hospital administration is also considering expanding the gynaecology department alongside the trauma centre launch. With the trauma wing shifting out of the main building, significant space will be vacant, which could be used to add more gynaecology beds. The department has long faced space shortages, despite handling a large volume of delivery cases from Chandigarh and neighbouring states like Punjab, Haryana, Himachal Pradesh, Uttarakhand, and Uttar Pradesh. Hospital authorities say the expansion of gynaecology and other departments will help meet the rising demand for healthcare services in the region.
Time of India
2 hours ago
- Time of India
Hosps asked to remain vigilant, maintain stock of essential items
Indore: A total of 41 Covid-19 positive cases were identified in Indore district so far, with 26 patients currently in isolation and undergoing treatment. This information was presented by the health department in a meeting held on Sunday to review the preparations to tackle the resurgence in cases. The meeting reviewed the Covid situation from January 2025 to the present. The health department stated that the current cases are of a very mild variant, similar to 'Omicron BA.2-like,' with no severe symptoms observed. Chairing the meeting, collector incharge Gaurav Benal instructed all hospitals to remain vigilant and adhere to Covid-19 protocol. Citizens are urged to use masks in crowded places, wash hands frequently, and contact the nearest health centre immediately if symptoms appear. Benal said, "Comprehensive measures for vigilance and precaution are being ensured to combat Covid-19 infection in Indore district. Citizens are encouraged not to panic but to remain cautious and get tested and treated promptly if symptoms appear. The situation in the district is fully under control." Benal instructed that all necessary preparations be maintained and an adequate stock of essential materials and medicines should be ensured. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo He directed officials to secure the supply chain arrangements and train the RRP team. In the meeting, it was informed that there is adequate sampling and testing arrangement in both govt and private hospitals. The meeting was attended by chief medical and health officer Dr BS Saitya, Dr Madhav Hasani, and directors of all govt and private hospitals in the district. Indore: A total of 41 Covid-19 positive cases were identified in Indore district so far, with 26 patients currently in isolation and undergoing treatment. This information was presented by the health department in a meeting held on Sunday to review the preparations to tackle the resurgence in cases. The meeting reviewed the Covid situation from January 2025 to the present. The health department stated that the current cases are of a very mild variant, similar to 'Omicron BA.2-like,' with no severe symptoms observed. Chairing the meeting, collector incharge Gaurav Benal instructed all hospitals to remain vigilant and adhere to Covid-19 protocol. Citizens are urged to use masks in crowded places, wash hands frequently, and contact the nearest health centre immediately if symptoms appear. Benal said, "Comprehensive measures for vigilance and precaution are being ensured to combat Covid-19 infection in Indore district. Citizens are encouraged not to panic but to remain cautious and get tested and treated promptly if symptoms appear. The situation in the district is fully under control." Benal instructed that all necessary preparations be maintained and an adequate stock of essential materials and medicines should be ensured. He directed officials to secure the supply chain arrangements and train the RRP team. In the meeting, it was informed that there is adequate sampling and testing arrangement in both govt and private hospitals. The meeting was attended by chief medical and health officer Dr BS Saitya, Dr Madhav Hasani, and directors of all govt and private hospitals in the district.
&w=3840&q=100)
Business Standard
3 hours ago
- Business Standard
New mRNA vaccine is more effective, less costly to develop, shows study
A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study by researchers at the University of Pittsburgh School of Public Health and the Pennsylvania State University. The study was published today in npj Vaccines. Though highly effective at inducing an immune response, current mRNA vaccines, such as those used to prevent COVID-19, present two significant challenges: the high amount of mRNA needed to produce them and the constantly evolving nature of the pathogen. "The virus changes, moving the goal post, and updating the vaccine takes some time," said senior author Suresh Kuchipudi, Ph.D., chair of Infectious Diseases and Microbiology at Pitt Public Health. To address these challenges, the researchers created a proof-of-concept COVID-19 vaccine using what's known as a "trans-amplifying" mRNA platform. In this approach, the mRNA is separated into two fragments -- the antigen sequence and the replicase sequence -- the latter of which can be produced in advance, saving crucial time in the event a new vaccine must be developed urgently and produced at scale. Additionally, the researchers analysed the spike-protein sequences of all known variants of SARS-CoV-2 for commonalities, rendering what's known as a "consensus spike protein" as the basis for the vaccine's antigen. In mice, the vaccine induced a robust immune response against many strains of SARS-CoV-2. "This has the potential for more lasting immunity that would not require updating, because the vaccine has the potential to provide broad protection," said Kuchipudi. "Additionally, this format requires an mRNA dose 40 times less than conventional vaccines, so this new approach significantly reduces the overall cost of the vaccine." The lessons learned from this study could inform more efficient vaccine development for other constantly evolving RNA viruses with pandemic potential, Kuchipudi said. "We hope to apply the principles of this lower-cost, broad-protection antigen design to pressing challenges like bird flu," added Kuchipudi.
